华森制药: 股票交易异常波动公告

Group 1 - The stock of Chongqing Huason Pharmaceutical Co., Ltd. experienced an abnormal trading fluctuation, with a cumulative price increase of 21.52% over two consecutive trading days on May 27 and May 28, 2025 [1][2] - The company's board confirmed that there were no undisclosed significant matters that could have impacted the stock price, and the operational situation remains normal without any major changes [1][2] - The controlling shareholder and actual controller did not engage in buying or selling the company's stock during the period of abnormal trading [2] Group 2 - The board of directors confirmed that there are no undisclosed matters that should be disclosed according to the Shenzhen Stock Exchange's regulations [2] - The company emphasized that it has not violated any information disclosure regulations and reminded investors to pay attention to potential risks as outlined in the 2024 annual report [2]